Contra Costa County Header
File #: 24-3847    Version: 1 Name:
Type: Consent Item Status: Passed
File created: 10/30/2024 In control: BOARD OF SUPERVISORS
On agenda: 11/12/2024 Final action: 11/12/2024
Title: APPROVE and AUTHORIZE the Health Services Director, or designee, to execute a contract with Bureau Veritas North America, Inc., in an amount not to exceed $70,000 to provide chemotherapy surface contamination testing services for the Contra Costa Regional Medical Center’s Chemotherapy Infusion Pharmacy for the period November 1, 2024 through October 31, 2025. (100% Hospital Enterprise Fund I)

To:                                          Board of Supervisors

From:                                          Anna Roth, Health Services Director

Report Title:                     Contract # 76-761-4 with Bureau Veritas North America, Inc.

Recommendation of the County Administrator Recommendation of Board Committee

 

RECOMMENDATIONS:

APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County, Contract #76-761-4 with Bureau Veritas North America, LLC, a limited liability company, in an amount not to exceed $70,000, to provide chemotherapy surface contamination testing services for the Contra Costa Regional Medical Center (CCRMC) Chemotherapy Infusion Pharmacy, for the period November 1, 2024 through October 31, 2025.

 

FISCAL IMPACT:

Approval of this Contract will result in annual expenditures of up to $70,000 and will be funded as budgeted by the department, 100% by Hospital Enterprise Fund I revenues.

 

BACKGROUND:

The County has an obligation to provide certain specialized surface contamination testing support services for the CCRMC Chemotherapy Infusion Pharmacy. These test samples are sent to the Contractor to be tested for possible chemotherapy contamination on our pharmacy surfaces. This Contractor has been providing these contamination testing services for the County and fostering a deep understanding of the CCRMC organizations mission, values, and long-term objectives since November 1, 2021. This Contract is entered into under and subject to the following legal authorities: California Government Code §§ 26227 and 31000; Health and Safety Code § 1451. The California State Board of Pharmacy and US Pharmacopeia (USP) 787 and 800 laws requires testing of all surfaces that come into contact with hazardous drugs to ensure employee and patient safety. Health Services Personnel approved this Contract to ensure no conflicts with labor relations.

 

Contractor currently cooperates with and participates in CCRMC’s Quality Assurance Program which consists of quality improvement activities such as assisting with the completion of CCRMC’s annual performance review. Contractor has a demonstrated history of maintaining the required accreditations and compliance with these federal regulations. This contractor has been approved by the Public Works Department’s Purchasing Division on October 8, 2024.

 

In September 2023, the County Administrator approved and the Purchasing Services Manager executed Contract #76-761-3 with Bureau Veritas North America, Inc., in an amount not to exceed $70,000, for the provision of chemotherapy surface contamination testing services for the CCRMC Chemotherapy Infusion Pharmacy, for the period November 1, 2023 through October 31, 2024. 

 

Approval of Contract #76-761-4 will allow the Contractor to continue to provide chemotherapy surface contamination testing services at the CCRMC Chemotherapy Infusion Pharmacy through October 31, 2025. This Contract limits the County and Contractor’s liability so that each party shall contribute the amount of its proportionate share. Neither party shall be liable for certain damages, including indirect or consequential, exemplary, punitive, or special damages. This Contract also modifies the County’s standard indemnification provision.

 

CONSEQUENCE OF NEGATIVE ACTION:

If this Contract is not approved, certain specialized chemotherapy surface contamination testing services for CCRMC will not be provided and may risk County not being in compliance with The California State Board of Pharmacy.